Cesarean surgical wound. Infection of obstetric surgical wound
Conditions
Interventions
Intervention 1: Intervention group A: Skin and vaginal prep, both chlorhexidine. Intervention 2: Intervention group B: Skin and vaginal prep, both Betadine. Intervention 3: Intervention group C: Chlor
Sponsors
Dana Pharmed Lotus
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Singleton pregnancy Prior planning for cesarean section and elective cesarean section Planned gestational age of at least 36 weeks at time of delivery• Written informed consent provided Intention to be available for the entire study period and complete all relevant study procedures, including follow-up visits and telephone calls Hemoglobin greater than 10 g/dL at time of admission
Exclusion criteria
Exclusion criteria: Body mass index greater than or equal to 40 at study entry Placenta previa or placental adhesions Previous intestinal or urological surgery Multiple pregnancy Known or suspected impairment of immunologic function, including infection with HIV, hepatitis B, or C Use of immunosuppressive drugs, chemotherapy, radiotherapy, or systemic corticosteroids within 4 weeks prior to surgery Known use of tobacco or narcotics and stimulants Any condition that, in the investigator's opinion, may pose a risk to the participant's health or interfere with the assessment of the study objectives. History of keloid or scar formation Participation in another clinical trial within the past three months Any significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, hematological, endocrine, metabolic, neurological, or psychological disease as determined by the physician Frequent vaginal swab examinations Emergency cesarean section Chorioamnionitis or other systemic infection at the time of presentation for cesarean section, including evidence of perianal skin infection (e.g., fungal infection)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical wound infection. Timepoint: Days 2, 10 and 30 after surgery. Method of measurement: According to the doctor's diagnosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmene Abiri
Tehran University of Medical Sciences
Outcome results
None listed